Additive impact of HER2-/PTK6-RNAi on interactions with HER3 or IGF-1R leads to reduced breast cancer progression in vivo.
about
Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.uPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R.Identification of cytotoxic agents disrupting synovial sarcoma oncoprotein interactions by proximity ligation assay.Cyr61 and YB-1 are novel interacting partners of uPAR and elevate the malignancy of triple-negative breast cancer.
P2860
Additive impact of HER2-/PTK6-RNAi on interactions with HER3 or IGF-1R leads to reduced breast cancer progression in vivo.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Additive impact of HER2-/PTK6- ...... st cancer progression in vivo.
@en
type
label
Additive impact of HER2-/PTK6- ...... st cancer progression in vivo.
@en
prefLabel
Additive impact of HER2-/PTK6- ...... st cancer progression in vivo.
@en
P2093
P2860
P1433
P1476
Additive impact of HER2-/PTK6- ...... ast cancer progression in vivo
@en
P2093
Heinz Höfler
Ines Höfig
Katrin Lindner
Ksenia Bashkueva
Michaela Aubele
Natalie Falkenberg
P2860
P304
P356
10.1016/J.MOLONC.2014.08.012
P577
2014-09-06T00:00:00Z